Autoimmune Pulmonary Alveolar Proteinosis Completed Phase 2 Trials for Regramostim (DB05386)

Back to Autoimmune Pulmonary Alveolar Proteinosis

Also known as: Pulmonary Alveolar Proteinosis, Autoimmune / Autoimmune pulmonary alveolar proteinosis (disorder) / Alveolar proteinosis / Pulmonary Alveolar Proteinosis / Pulmonary alveolar proteinosis (disorder)

Indication	Status	Phase
DBCOND0075037 (Autoimmune Pulmonary Alveolar Proteinosis)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02702180	Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis	Treatment	Molgramostim (DB12525) Regramostim (DB05386)